Economics
Goldman Economists See Drug Epidemic Taking Toll on U.S. Economy
- Crisis reinforces doubts about rebound in participation rate
- Goldman economists say drug deaths probably overstate impact
FDA Makes Opioid Abuse a Top Priority
This article is for subscribers only.
Goldman Sachs Group Inc. economists say America’s opioid epidemic is probably sidelining people in their prime working years and contributing to the stubbornly low rate of men and women who are either employed or looking for jobs.
“Use of both legal prescription pain relievers and illegal drugs is part of the story of declining prime-age participation, especially for men,” Goldman economists wrote in the study released Wednesday.